Trials / Terminated
TerminatedNCT03943511
Discharged With Indwelling Chest Tube and Valve
A Randomized Study Evaluating Patients Discharged With Indwelling Chest Tube and Valve
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, randomized trial for the treatment of subjects discharging from the hospital with a chest tube and valve in place. Subjects will be randomized to receive oral antibiotics and close monitoring, defined as twice weekly telephone calls by a member of the care team, of their chest tube and valve or standard of care, defined as no calls from the care team but waiting for the subject to contact the care team when the air leak has stopped.
Detailed description
This study is a multicenter, randomized trial for the treatment of subjects discharging from the hospital with a chest tube and valve in place. Subjects will be screened prior to discharging from the hospital and interested qualified subjects will be consented and offered participation in this trial. Once consent has been obtained the subject will be randomized to receive oral antibiotics and close monitoring, defined as twice weekly telephone calls by a member of the care team, of their chest tube and valve or standard of care, defined as no calls from the care team but waiting for the subject to contact the care team when the air leak has stopped. The subject will be followed until they have their chest tube removed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Oral Antibiotics-Close Monitoring | To receive oral antibiotics and close monitoring, defined as twice weekly telephone calls by a member of the care team, of their chest tube and valve. |
| OTHER | Standard of Care | No calls from the care team but waiting for the subject to contact the care team when the air leak has stopped. |
Timeline
- Start date
- 2019-10-07
- Primary completion
- 2023-11-20
- Completion
- 2023-11-20
- First posted
- 2019-05-09
- Last updated
- 2025-10-07
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03943511. Inclusion in this directory is not an endorsement.